Please assess the completion status of the following clinical trial:

Trial Title: Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Informed Consent~* Male or female subjects 12 years of age or older~* Documented history of season allergic rhinitis to mountain cedar pollen~* General good health~* Other criteria apply~Exclusion Criteria:~* History of physical findings of nasal pathology (within 60 days prior to screening visit)~* Participation in any investigational drug study 30 days preceding screening visit~* History of respiratory infection/disorder with 14 days preceding screening visit~* Use of any prohibited concomitant medications~* Other criteria apply

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BDP HFA 320 µg/day (Type: EXPERIMENTAL): During the 2-week double-blind Treatment Period participants self-administered 4 actuations (two per nostril) of 80 µg BDP HFA once daily each morning.
- Placebo (Type: PLACEBO_COMPARATOR): During the 2-week double-blind Treatment Period participants self-administered four actuations (two per nostril) of placebo HFA once daily each morning.

Based on this trial design, predict the completion outcome and termination type (if applicable).